Barely Significant
← all excerpts

Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER).

MedComm (2020) · 2025 · PMC12514558 · PMID 41079649

3
hedged sentences
0.0750
closest p · 1.5× alpha
0.0750
boldest claim

The sentences

showed a trendp = 0.075so close (0.05 < p ≤ 0.1)
Additionally, baseline carcinoembryonic antigen (CEA) levels were significantly associated with CCCA at T1 (Figure 3F ), and histological grade showed a trend toward association ( p = 0.075; Figure 3E ).

also in 53,322 other papers

a decreasing trendno p-value reported
As neoadjuvant therapy progressed, the levels of most proteins exhibited a decreasing trend (Figures 6F and S5 ).

also in 47,180 other papers

Circulating Tumor DNA While ctDNA was detectable in some MRs at T0 + , T2, S, and PO, it was consistently undetectable in all GRs at the same time points, although the difference did not reach statistical significance (Figure 4B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.